Substance Use Tools & Resources    

Includes information for healthcare professionals, professional and patient organizations, and community groups, including tips for getting started, fact sheets on the requirements for providing chronic care management in practices, and educational materials to share with patients.

The Drug Free Moms and Babies (DFMB) Project is a comprehensive and integrative medical and behavioral health program for pregnant and postpartum women. The project supports healthy baby outcomes by providing prevention, early intervention, addiction treatment, and recovery support services.

Provides an overview of neonatal abstinence syndrome (NAS) and how opiate exposure during pregnancy may affect a newborn.

On online resource to train people to respond effectively to an opioid overdose emergency.

The brief is intended primarily for physicians and other prescribers as well as support staff, administrators, and caregivers working with people with dementia and intellectual and developmental disabilities (IDD) in community settings. To reduce inappropriate prescribing, this brief reviews non-pharmacologic behavioral approaches and strategies to avoid and reduce prescribing of antipsychotics whenever possible.

Outlines the process of developing and managing an overdose prevention and education program, with or without a take-home naloxone component.

Provides guidelines that can improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose.

This HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics provides advice to clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid thera

Provides information about when healthcare professionals are legally allowed to disclose some health information related to OUD without a patient's permission.

Discusses how a prescribing physician may prepare for a DEA visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine and involve topics such as prescription and dispensing records and adherence to prescribing limits on number of patients.